Company Filing History:

15 out of 362

Smith Kline & French Laboratories Limited

Boehringer Mannheim Gmbh

patents

4. 1 out of 1

Sk&f Laboratories Ltd.

patent

where one patent can have more than one assignee

Years Active: 1983-2013

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8481566 - Compounds which have activity at M1 receptor and their uses in medicine (2013-07-09),

2. 8426443 - [object Object] (2013-04-23),

3. 8344000 - [object Object] (2013-01-01),

4. 8299257 - [object Object] (2012-10-30),

5. 8288413 - Benzimidazolones which have activity at M1 receptor (2012-10-16),

6. 8288412 - [object Object] (2012-10-16),

7. 8283364 - [object Object] (2012-10-09),

8. 8278328 - [object Object] (2012-10-02),

9. 5338752 - Substituted 2-imidazolone derivatives, their preparation and (1994-08-16),

10. 5280043 - Sulphonamido containing phenylalkanoic acids as thromboxane A.sub.2 (1994-01-18),

11. 5098701 - Crosslinked pyridinomethacrylate polymers (1992-03-24),

12. 4997847 - Biologically active compounds (1991-03-05),

13. 4902698 - Benzenesulphonamidopyridyl compounds which are useful as thromboxane A.sub. (1990-02-20),

14. 4894372 - Pyridine compounds which have useful histamine-H.sub.2 antagonist (1990-01-16),

15. 4863933 - 3-hydroxypyridines (1989-09-05),

Title: David G Cooper: Pioneer in Psychopharmacology

Introduction

David G Cooper is an esteemed inventor based in Letchworth, GB, known for his significant contributions to the field of medical chemistry. With a remarkable portfolio of 24 patents, Cooper's innovations primarily focus on compounds that exhibit activity at the M1 receptor, which play a crucial role in treating various psychological conditions.

Latest Patents

Among his latest patents, Cooper has developed compounds described in the formula (I) that demonstrate potential therapeutic uses in medicine. These compounds, along with their salts and solvates, feature various substitutions for R, which include fluoro or other halogens, and structurally diverse counterparts like alkyls and alkoxy groups. The significance of these compounds lies in their potential applications against psychotic disorders and cognitive impairment, including Alzheimer's Disease. Furthermore, his patents disclose pharmaceutical compositions that comprise these innovative compounds, thereby paving the way for novel treatment methodologies.

Career Highlights

Cooper's career has been marked by affiliations with reputable establishments like Smith Kline & French Laboratories Limited and Glaxo Group Limited. His extensive experience in these companies has allowed him to contribute meaningfully to research and development in the pharmaceutical domain.

Collaborations

Throughout his professional journey, Cooper has collaborated with notable colleagues, including George S Sach and Ian Thomson Forbes. These partnerships have not only fueled innovation but have also led to the advancement of crucial pharmaceutical developments.

Conclusion

David G Cooper's work in research and development in the pharmaceutical realm exemplifies a deep commitment to addressing complex medical challenges. His innovative compounds and extensive patent portfolio highlight his role as a leading figure in psychopharmacology, ultimately contributing to improved therapies for mental health disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.